This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Life sciences

Shaping the evolution of the industry

Life Sciences companies are experiencing a period of unprecedented change. Driven by shifts in age and demographics, disease, the entry of new technologies, increased government regulations, and the pace of health care inflation, life sciences companies will have to dramatically change in order to cope with the future industry environment.

Deloitte helps Life Sciences companies by providing extensive depth of knowledge on the range of current issues experienced in the pharmaceutical, biotech, and medical devices sectors.

Submit a request for proposal

Focus on

  • Approach to productive and innovative R&D
    This article describes Deloitte’s capabilities-based view of R&D that has allowed Life Sciences companies to better understand the strengths and challenges of each component of their R&D organization. This methodology is designed to help executives align R&D activities to their strategic business objectives.
  • The future of the life sciences industries
    As life sciences companies face many challenges, survey results show how the industry is transforming during a period of increased risk.
  • Executing and sustaining R&D strategy
    This article describes how R&D organizations can become more effective in the execution of strategies and demonstrates how this would increase the likelihood of achieving the expected, lasting benefits of their strategies.

Contact

Bert Hanique
Partner
Tel: +31 (0)88 288 19 55

Dbriefs Webcasts

  • Life sciences webcasts
    Register here for upcoming webcasts on topics related to the life sciences industry

Deloitte RSS feed  Deloitte YouTube  Deloitte Google+  Deloitte Facebook  Deloitte LinkedIn  Deloitte Twitter 

© 2014. See legal for more information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see deloitte.nl/about for a more detailed description of DTTL and its member firms.

In The Netherlands the services are provided by independent subsidiaries or affiliates of Deloitte Holding B.V., an entity which is registered with the trade register in The Netherlands under number 40346342.